Ronald Daniels - Director, Bridgebio Pharma, Inc

As of December 30, 2021


Ronald Daniels Net Worth

  • Net worth is estimated to be at least $241.04K
  • Owns at least 10,402 units of Bridgebio Pharma, Inc stock
  • Sold an estimated value of $150.34K in the last year at Bridgebio Pharma, Inc

Ronald Daniels Trading

  • Largest purchase of shares was 22,147 units , worth over $298.68K on December 30, 2021
  • Largest sale of shares was 11,745 units , worth over $150.34K on December 30, 2021
  • In total has made about 3 transactions over a year
  • Usually trades in February, June and December, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Ronald Daniels Mailing Address

  • Mailing address is C/o Moore Corporation Limited One Canterbury Green Stamford CT 06901 CT

Bridgebio Pharma, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Neil Kumar, Ph.D. 2020 $550,000 $825,000 $2,368,511 $6,299,998 $11,400 $10,054,909
Neil Kumar, Ph.D. 2019 $502,765 $360,000 $13,863,445 $11,573,049 $34,804 $26,334,063
Neil Kumar, Ph.D. 2018 $450,000 - - - - $450,000
Brian Stephenson, Ph.D., CFA 2020 $550,000 $712,500 $789,494 $2,099,996 $11,943 $4,163,933
Brian Stephenson, Ph.D., CFA 2019 $420,000 $189,000 $132,600 $3,430,781 $26,586 $4,198,967
Brian Stephenson, Ph.D., CFA 2018 $74,375 $330,240 $1,942,500 - - $2,347,115
Michael Henderson, M.D. 2020 $515,000 $300,000 $7,072,500 $91,899 $11,843 $7,991,241
Cameron Turtle, Ph.D.* 2020 $400,000 $210,000 $3,940,081 - $11,400 $4,561,482
Charles Homcy, M.D. 2020 $500,000 $100,000 - $1,199,992 $55,812 $1,855,805
Charles Homcy, M.D. 2019 $513,808 - $2,111,579 $3,128,716 $221,737 $5,975,842
Brian Stolz 2020 $511,362 $25,000 $736,854 $1,992,182 $1,975,453 $5,240,851
Brian Stolz 2019 $146,780 $93,750 $6,860,780 $1,045,003 - $8,146,313
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1743881/000119312521145491/d131567ddef14a.htm

Bridgebio Pharma, Inc Insider Trading

  • The most recent transaction was 12,000 units bought on March 17, 2022 by Andrea Ellis worth over $100.68K
  • In the last 3 years, insiders at Bridgebio Pharma, Inc sold an estimated value of $351.74M and bought an estimated value of $213.34M
  • The most active traders are Neil Kumar, CEO and President,  Brian C Stephenson, See Remarks,  and Thomas Michael Henderson, Chief Business Officer
  • Insider trading is most common in June, with the busiest year in 2020

BridgeBio Pharma, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1